IBIO, INC. Current Liabilities
IBIO, INC. (IBIO) had Current Liabilities of $11.74 million as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-28
- 2026-06-30: Liabilities, Current $11.74M.
- 2026-03-31: Liabilities, Current $6.50M.
- 2025-12-31: Liabilities, Current $5.90M.
- 2025-09-30: Liabilities, Current $6.05M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.74M 10-K · filed 2026-08-28 | |
| 2026-03-31 | $6.50M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $5.90M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $6.05M 10-Q/A · filed 2025-11-17 | |
| 2025-06-30 | $6.11M 10-K · filed 2026-08-28 | |
| 2025-03-31 | $5.40M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $4.71M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $3.47M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.84M 10-K · filed 2025-09-05 | |
| 2024-03-31 | $21.43M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $21.55M 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $20.71M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $22.11M 10-K/A · filed 2024-09-24 | $21.58M 10-K · filed 2023-09-27 |
| 2023-03-31 | $22.28M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $27.77M 10-Q/A · filed 2023-05-19 | |
| 2022-09-30 | $32.20M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.44M 10-K · filed 2023-09-27 | |
| 2022-03-31 | $8.28M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $8.35M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $8.10M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $6.64M 10-K · filed 2022-10-11 | |
| 2021-03-31 | $6.07M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.10M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $5.05M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $5.24M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $6.18M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $4.74M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $4.87M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.46M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $4.05M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $4.45M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $5.04M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $2.04M 10-K · filed 2019-08-26 | |
| 2018-03-31 | $1.95M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $2.04M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $2.11M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.01M 10-K · filed 2018-09-18 | |
| 2017-03-31 | $2.62M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.87M 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $2.17M 10-Q · filed 2016-11-18 | |
| 2016-06-30 | $2.29M 10-K · filed 2017-09-15 | |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-23 | |
| 2015-06-30 | $1.26M 10-K · filed 2016-10-13 | |
| 2014-12-31 | $1.48M 10-Q · filed 2015-02-24 | |
| 2014-09-30 | $1.22M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $395.00K 10-Q · filed 2015-02-24 | |
| 2014-03-31 | $1.21M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.66M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $1.65M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $4.29M 10-K · filed 2014-09-29 | |
| 2013-03-31 | $2.68M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $3.09M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $3.42M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $3.60M 10-K/A · filed 2013-10-04 | $3.60M 10-K/A · filed 2012-10-15 |
| 2012-03-31 | $3.80M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $4.71M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $4.69M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $7.14M 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |